JP2012518649A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518649A5
JP2012518649A5 JP2011551274A JP2011551274A JP2012518649A5 JP 2012518649 A5 JP2012518649 A5 JP 2012518649A5 JP 2011551274 A JP2011551274 A JP 2011551274A JP 2011551274 A JP2011551274 A JP 2011551274A JP 2012518649 A5 JP2012518649 A5 JP 2012518649A5
Authority
JP
Japan
Prior art keywords
subject
substituted
unsubstituted
pharmaceutical composition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551274A
Other languages
English (en)
Japanese (ja)
Other versions
JP5600329B2 (ja
JP2012518649A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/024920 external-priority patent/WO2010096764A1/en
Publication of JP2012518649A publication Critical patent/JP2012518649A/ja
Publication of JP2012518649A5 publication Critical patent/JP2012518649A5/ja
Application granted granted Critical
Publication of JP5600329B2 publication Critical patent/JP5600329B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551274A 2009-02-23 2010-02-22 イミノ糖およびウイルス性疾患を治療する方法 Expired - Fee Related JP5600329B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20236709P 2009-02-23 2009-02-23
US61/202,367 2009-02-23
US27225509P 2009-09-04 2009-09-04
US61/272,255 2009-09-04
PCT/US2010/024920 WO2010096764A1 (en) 2009-02-23 2010-02-22 Iminosugars and methods of treating viral diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014165290A Division JP5940607B2 (ja) 2009-02-23 2014-08-14 イミノ糖およびウイルス性疾患を治療する方法

Publications (3)

Publication Number Publication Date
JP2012518649A JP2012518649A (ja) 2012-08-16
JP2012518649A5 true JP2012518649A5 (https=) 2014-04-17
JP5600329B2 JP5600329B2 (ja) 2014-10-01

Family

ID=42634239

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011551274A Expired - Fee Related JP5600329B2 (ja) 2009-02-23 2010-02-22 イミノ糖およびウイルス性疾患を治療する方法
JP2014165290A Expired - Fee Related JP5940607B2 (ja) 2009-02-23 2014-08-14 イミノ糖およびウイルス性疾患を治療する方法
JP2016099696A Pending JP2016175937A (ja) 2009-02-23 2016-05-18 イミノ糖およびウイルス性疾患を治療する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014165290A Expired - Fee Related JP5940607B2 (ja) 2009-02-23 2014-08-14 イミノ糖およびウイルス性疾患を治療する方法
JP2016099696A Pending JP2016175937A (ja) 2009-02-23 2016-05-18 イミノ糖およびウイルス性疾患を治療する方法

Country Status (8)

Country Link
US (4) US8450345B2 (https=)
EP (1) EP2398321B1 (https=)
JP (3) JP5600329B2 (https=)
KR (2) KR101755133B1 (https=)
CN (2) CN106420740A (https=)
CA (1) CA2753195C (https=)
ES (1) ES2579628T3 (https=)
WO (1) WO2010096764A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150035767A (ko) 2012-06-06 2015-04-07 유니터 바이롤로지, 엘엘씨 신규 이미노당 및 그의 용도
JP2016513729A (ja) * 2013-03-15 2016-05-16 ユニザー ヴィロロジー,エルエルシー 抗菌化合物
JP6456393B2 (ja) 2013-09-16 2019-01-23 エマージェント バイロロジー エルエルシー デオキシノジリマイシン誘導体およびその使用方法
BR112017008898B1 (pt) 2014-11-05 2022-11-29 Emergent Virology Llc Compostos de iminoaçúcares, suas composições farmacêuticas e usos dos mesmos para tratar doenças virais
WO2017201052A1 (en) * 2016-05-16 2017-11-23 Emergent Virology Llc Methods of treating zika virus infection
KR101942757B1 (ko) 2017-08-23 2019-01-28 주식회사 유앤아이미트 마이크로웨이브를 이용한 n-노닐데옥시노지리마이신의 제조방법
CN113425720A (zh) * 2020-04-03 2021-09-24 深圳前海诺贝尔奖科学家技术转移转化有限公司 亚胺糖化合物在制备抗SARS-CoV-2病毒的药物中的用途
CN119841765B (zh) * 2025-01-09 2025-10-10 中南大学 Dnj衍生物、药物组合物及其应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2834122A1 (de) * 1978-08-03 1980-02-14 Bayer Ag Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
DE2853573A1 (de) * 1978-12-12 1980-07-03 Bayer Ag Herstellung von n-substituierten derivaten des l-desoxynojirimycins
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5103008A (en) * 1989-08-17 1992-04-07 Monsanto Company Compound, N-butyl-deoxynojirimycin-6-phosphate
US4994572A (en) * 1989-10-12 1991-02-19 Monsanto Company Synthesis of nojirimycin derivatives
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
KR20010033028A (ko) * 1997-12-11 2001-04-25 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 막-관련 바이러스 복제의 억제
DE69932154T2 (de) 1998-02-12 2007-05-31 G.D. Searle Llc, Chicago Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
EP1714676A3 (en) 1998-02-12 2006-11-15 G.D. Searle LLC. Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
US6689759B1 (en) * 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6610703B1 (en) 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB9828474D0 (en) * 1998-12-24 1999-02-17 British Aerospace Surface topology inspection
ATE402701T1 (de) * 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
EP1196190B1 (en) * 1999-07-26 2003-03-19 G.D. SEARLE & CO. Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases
US7256005B2 (en) * 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
CN1694696A (zh) * 2002-09-23 2005-11-09 牛津大学校委会 亚氨基糖衍生物在抑制离子通道活性中的应用
EP2857036B1 (en) * 2003-01-31 2016-12-21 Mount Sinai School of Medicine of New York University Combination therapy for treating protein deficiency disorders
US7446098B2 (en) 2003-02-18 2008-11-04 Mount Sinai School Of Medicine Of New York University Combination therapy for treating protein deficiencies
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US20050256168A1 (en) * 2004-04-28 2005-11-17 Block Timothy M Compositions for oral administration for the treatment of interferon-responsive disorders
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
GB0501352D0 (en) 2005-01-21 2005-03-02 Slingsby Jason H Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
US7638488B2 (en) 2005-03-08 2009-12-29 Intermune, Inc. Use of alpha-glucosidase inhibitors to treat alphavirus infections
CA2601797A1 (en) * 2005-03-16 2006-09-21 University Of Oxford Mannose immunogens for hiv-1
EP3782655A1 (en) * 2005-05-17 2021-02-24 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
KR20080031474A (ko) * 2005-07-27 2008-04-08 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. 안구 질환의 치료를 위한 열충격의 사용
US20100004156A1 (en) * 2005-07-27 2010-01-07 Shalesh Kaushal Small Compounds That Correct Protein Misfolding and Uses Thereof
US20070244184A1 (en) * 2006-01-09 2007-10-18 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
DE602007008870D1 (de) * 2006-04-24 2010-10-14 Amc Amsterdam Verbessertes verfahren zur behandlung von cystischer fibrose
CN104876855A (zh) * 2006-05-24 2015-09-02 联合治疗公司 脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法
JP2009545621A (ja) 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
KR20090057035A (ko) * 2006-08-21 2009-06-03 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 치료를 위한 병용 요법
WO2008068548A1 (en) 2006-12-08 2008-06-12 Institut Necker Use of inhibitors of the glycosylation process for the prevention and treatment of genetic diseases
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
EP2400843B1 (en) 2009-02-24 2015-11-11 United Therapeutics Corporation Iminosugars and methods of treating arenaviral infections
US8703744B2 (en) 2009-03-27 2014-04-22 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
ES2524361T3 (es) 2009-06-12 2014-12-05 United Therapeutics Corporation Iminoazúcares para su uso en el tratamiento de enfermedades por bunyavirus y togavirus
JP5653438B2 (ja) 2009-09-04 2015-01-14 ユナイテッド セラピューティクス コーポレイション オルトミクソウイルス感染の治療方法
CA2772813A1 (en) 2009-09-04 2011-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Iminosugars and methods of treating filoviral diseases
CA2772807A1 (en) 2009-09-04 2011-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Methods of treating poxviral infections

Similar Documents

Publication Publication Date Title
JP2012518649A5 (https=)
JP2013503881A5 (https=)
JP2009504763A5 (https=)
JP2012092103A5 (https=)
JP2009536660A5 (https=)
JP2013503880A5 (https=)
JP2013512915A5 (https=)
JP2013032389A5 (https=)
JP2013507423A5 (https=)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2013503846A5 (https=)
JP2008509166A5 (https=)
JP2014506907A5 (https=)
JP2011037841A5 (https=)
JP2013545785A5 (https=)
EA201201031A1 (ru) Ингибиторы вируса гепатита с
JP2013510120A5 (https=)
JP2013518107A5 (https=)
JP2008533007A5 (https=)
JP2019526596A5 (https=)
JP2015535847A5 (https=)
JP2014500861A5 (https=)
JP2015504081A5 (https=)
JP2012532883A5 (https=)
JP2010529994A5 (https=)